Merel O. Mol

3.8k total citations
17 papers, 228 citations indexed

About

Merel O. Mol is a scholar working on Molecular Biology, Physiology and Neurology. According to data from OpenAlex, Merel O. Mol has authored 17 papers receiving a total of 228 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Physiology and 7 papers in Neurology. Recurrent topics in Merel O. Mol's work include Alzheimer's disease research and treatments (8 papers), Amyotrophic Lateral Sclerosis Research (6 papers) and Dementia and Cognitive Impairment Research (5 papers). Merel O. Mol is often cited by papers focused on Alzheimer's disease research and treatments (8 papers), Amyotrophic Lateral Sclerosis Research (6 papers) and Dementia and Cognitive Impairment Research (5 papers). Merel O. Mol collaborates with scholars based in Netherlands, United States and Germany. Merel O. Mol's co-authors include John C. van Swieten, Jeroen van Rooij, Shamiram Melhem, Harro Seelaar, Laura Donker Kaat, Suzanne S. M. Miedema, Elise G.P. Dopper, Annemieke J.M.H. Verkerk, Amel Dudakovic and Rebekah M. Samsonraj and has published in prestigious journals such as Journal of Biological Chemistry, Brain and International Journal of Molecular Sciences.

In The Last Decade

Merel O. Mol

14 papers receiving 226 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Merel O. Mol Netherlands 10 118 68 61 35 32 17 228
Vincenzo Montano Italy 11 133 1.1× 47 0.7× 48 0.8× 43 1.2× 27 0.8× 28 276
Karolina Minta Sweden 13 116 1.0× 105 1.5× 58 1.0× 44 1.3× 50 1.6× 19 293
Ashley C. Knight United States 8 128 1.1× 63 0.9× 33 0.5× 45 1.3× 28 0.9× 11 287
Jamie N. Mayo United States 8 152 1.3× 57 0.8× 41 0.7× 57 1.6× 47 1.5× 14 328
Domitille Gras France 7 79 0.7× 104 1.5× 60 1.0× 50 1.4× 14 0.4× 16 259
Axel Meneses United States 4 92 0.8× 102 1.5× 104 1.7× 34 1.0× 55 1.7× 4 237
Milena Janković Serbia 12 106 0.9× 79 1.2× 152 2.5× 91 2.6× 40 1.3× 37 337
Masanori Fukumoto Japan 12 168 1.4× 46 0.7× 52 0.9× 44 1.3× 41 1.3× 70 480
Youn Joo Moon South Korea 9 84 0.7× 22 0.3× 100 1.6× 54 1.5× 31 1.0× 12 334
Grant C. Walters United States 6 195 1.7× 52 0.8× 29 0.5× 63 1.8× 55 1.7× 7 310

Countries citing papers authored by Merel O. Mol

Since Specialization
Citations

This map shows the geographic impact of Merel O. Mol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Merel O. Mol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Merel O. Mol more than expected).

Fields of papers citing papers by Merel O. Mol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Merel O. Mol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Merel O. Mol. The network helps show where Merel O. Mol may publish in the future.

Co-authorship network of co-authors of Merel O. Mol

This figure shows the co-authorship network connecting the top 25 collaborators of Merel O. Mol. A scholar is included among the top collaborators of Merel O. Mol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Merel O. Mol. Merel O. Mol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Lev‐Ram, Varda, Daniela Bertinetti, Andrew J. Hoy, et al.. (2025). Allosteric modulation of protein kinase A in individuals affected by NLPDPKA , a neurodegenerative disease in which the PRKAR1B L50R variant is expressed. FEBS Journal. 292(18). 4808–4832.
2.
Miedema, Suzanne S. M., Merel O. Mol, Iryna Paliukhovich, et al.. (2025). Proteomics of the temporal cortex in semantic dementia reveals brain-region specific molecular pathology and regulation of the TDP-43-ANXA11 interactome. Acta Neuropathologica Communications. 13(1). 162–162.
3.
Mol, Merel O., Tjakko J. van Ham, Natalja Bannink, et al.. (2024). Biallelic and monoallelic variants in EFEMP1 can cause a severe and distinct subtype of heritable connective tissue disorder. European Journal of Human Genetics. 32(12). 1567–1573.
4.
Eikelboom, Willem S., Esther van den Berg, Casper de Boer, et al.. (2023). The reporting of neuropsychiatric symptoms in electronic health records of individuals with Alzheimer’s disease: a natural language processing study. Alzheimer s Research & Therapy. 15(1). 94–94. 5 indexed citations
5.
Giannini, Lucia, Merel O. Mol, Daniel T. Ohm, et al.. (2023). Presymptomatic and early pathological features of MAPT-associated frontotemporal lobar degeneration. Acta Neuropathologica Communications. 11(1). 126–126. 1 indexed citations
6.
Mol, Merel O., Sven J. van der Lee, Marc Hulsman, et al.. (2022). Mapping the genetic landscape of early-onset Alzheimer’s disease in a cohort of 36 families. Alzheimer s Research & Therapy. 14(1). 77–77. 8 indexed citations
7.
Miedema, Suzanne S. M., Merel O. Mol, Frank Koopmans, et al.. (2022). Distinct cell type-specific protein signatures in GRN and MAPT genetic subtypes of frontotemporal dementia. Acta Neuropathologica Communications. 10(1). 100–100. 17 indexed citations
8.
Scarioni, Marta, Priya Gami‐Patel, Carel F.W. Peeters, et al.. (2022). Psychiatric symptoms of frontotemporal dementia and subcortical (co-)pathology burden: new insights. Brain. 146(1). 307–320. 14 indexed citations
9.
Mol, Merel O., Suzanne S. M. Miedema, Shamiram Melhem, et al.. (2022). Proteomics of the dentate gyrus reveals semantic dementia specific molecular pathology. Acta Neuropathologica Communications. 10(1). 190–190. 7 indexed citations
10.
Mol, Merel O., Suzanne S. M. Miedema, John C. van Swieten, Jeroen van Rooij, & Elise G.P. Dopper. (2021). Molecular Pathways Involved in Frontotemporal Lobar Degeneration with TDP-43 Proteinopathy: What Can We Learn from Proteomics?. International Journal of Molecular Sciences. 22(19). 10298–10298. 13 indexed citations
11.
Mol, Merel O., Tsz Hang Wong, Shamiram Melhem, et al.. (2021). Novel TUBA4A Variant Associated With Familial Frontotemporal Dementia. Neurology Genetics. 7(3). e596–e596. 18 indexed citations
12.
Dudakovic, Amel, Rebekah M. Samsonraj, Christopher R. Paradise, et al.. (2020). Inhibition of the epigenetic suppressor EZH2 primes osteogenic differentiation mediated by BMP2. Journal of Biological Chemistry. 295(23). 7877–7893. 58 indexed citations
13.
Rooij, Jeroen van, Merel O. Mol, Shamiram Melhem, et al.. (2020). SomaticTARDBPvariants as a cause of semantic dementia. Brain. 143(12). 3827–3841. 17 indexed citations
14.
Poos, Jackie M., Lize C. Jiskoot, Sophie Leijdesdorff, et al.. (2020). Cognitive profiles discriminate between genetic variants of behavioral frontotemporal dementia. Journal of Neurology. 267(6). 1603–1612. 13 indexed citations
15.
Mol, Merel O., Jeroen van Rooij, Tsz Hang Wong, et al.. (2020). Underlying genetic variation in familial frontotemporal dementia: sequencing of 198 patients. Neurobiology of Aging. 97. 148.e9–148.e16. 25 indexed citations
16.
Mol, Merel O., Jeroen van Rooij, Esther Brusse, et al.. (2020). Clinical and pathologic phenotype of a large family with heterozygous STUB1 mutation. Neurology Genetics. 6(3). e417–e417. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026